ArticleOrphanet journal of rare diseases2025

Real-world analysis of the efficacy and safety of nusinersen in pediatric patients with spinal muscular atrophy.

Wenjing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.